1
Back
Movement Disorders cover

Movement Disorders

IF7.6
Papers11336
Citations33392
Journal Papers 44702
Publication Date
delete
Joint Risk Factor Combinations with Additive Interaction Increase the Risk of Parkinson's Disease
deleteMovement Disorders
IF7.6
delete2026-08-12
delete0
deleteOAAI
deleteAndrea Quattrone MD, PhD; Basilio Vescio PhD; Fulvia Arcuri BSc; Giuseppe Chiarella MD; Jolanda Buonocore MD; Aldo Quattrone MD
deleteShare
deleteSave
Reply to: “Alkaline phosphatases as a potential source of variability in foslevodopa response: Muscles beyond pharmacokinetics”
deleteMovement Disorders
IF7.6
delete2026-08-10
delete0
PREAI
deleteManon Auffret PharmD, PhD, DAAN; Marc Vérin MD, PhD
deleteShare
deleteSave
COVID-19 Amplifies Sex-Specific Dopamine and Glial Responses in a Parkinson's Disease Mouse Model
deleteMovement Disorders
IF7.6
delete2026-08-10
delete0
deleteOAAI
deleteIfeoluwa Awogbindin PhD; Mélanie Bourque PhD; Marc Morissette PhD; Marie-Ève Hamelin PhD; Chantal Rhéaume AHT; Jared VanderZwaag MSc; Antonia Landwehr MSc
deleteShare
deleteSave
Reply to: “Dual Anatomical Targeting or Dual-Target Stimulation in Tremor-Dominant Parkinson's Disease?”
deleteMovement Disorders
IF7.6
delete2026-08-10
delete0
PREAI
deleteZhengyu Lin MD, MSc; Dianyou Li MD, PhD
deleteShare
deleteSave
Type 2 α-Synuclein Seed Amplification as a Diagnostic Reassessment Signal in Parkinson's Progression Markers Initiative Parkinson's Disease
deleteMovement Disorders
IF7.6
delete2026-08-10
delete0
PREAI
deleteAishanjiang Yusufujiang MD; Shan Zeng MD; Hongyan Li
deleteShare
deleteSave
Dual Anatomical Targeting or Dual-Target Stimulation in Tremor-Dominant Parkinson's Disease?
deleteMovement Disorders
IF7.6
delete2026-08-10
delete0
PREAI
deleteAntonella Macerollo MD, PhD, FRCP; Jibril Osman Farah MD, FRCS
deleteShare
deleteSave
Alkaline Phosphatases as a Potential Source of Variability in Foslevodopa Response: Muscles beyond Pharmacokinetics
deleteMovement Disorders
IF7.6
delete2026-08-10
delete0
PREAI
deleteFabienne Ory-Magne MD; David Devos MD, PhD; Guillaume Baille MD, PhD
deleteShare
deleteSave
Expanded ATXN3 CAG Repeat is Stable in Human Purkinje Cells
deleteMovement Disorders
IF7.6
delete2026-08-10
delete0
deleteOAAI
deleteHasnahana Chetia PhD; Laura Kus PhD; Erika Sipos BS; Nathaniel Heintz PhD; Kert Mätlik PhD
deleteShare
deleteSave
Early Longitudinal Brain Network Changes in Huntington's Disease Before Clinical Motor Onset
deleteMovement Disorders
IF7.6
delete2026-08-10
delete0
deleteOAAI
deleteMichela Leocadi PhD, AFHEA; Nicola Z. Hobbs PhD; Mena Farag MBBS, MRCP, PhD; Michael J. Murphy MB, BCh, BAO, MRCPI; Kate Fayer MRes; Olivia Thackeray MSc; Harry Knights MBBS, MRCP; James B. Rowe BA, BM, BCh, PhD, FRCP, FMedSci; Trevor W. Robbins CBE, FRS, FMedSci, FBPsS, FBPhS, PhD; Barbara J. Sahakian CBE, FBA, FMedSci, DSc, PhD, DipClinPsych; Geraint Rees BM, BCh, PhD, FMedSci; Rachael I. Scahill PhD; Sarah J. Tabrizi CBE, MBChB, FRCP, PhD, FMedSci; Christelle Langley PhD, AFBPsS
deleteShare
deleteSave
Cannabis-Based Oil for Pain and Other Non-Motor Symptoms in Parkinson's Disease: A Randomized Controlled Trial
deleteMovement Disorders
IF7.6
delete2026-08-10
delete0
deleteOAAI
deleteGabriel T. Kubota MD, PhD; Jacy B. Parmera MD, PhD; Matheus Deltreggia MD; Pedro N. Martins MD; Anna Letícia M. Alves MD; Ananda C.M. de Falcone MD; Ana Rosa Santana MD
deleteShare
deleteSave
Rare Heterozygous Loss-of-Function Variants in MCOLN1 Identified in Two Sporadic Patients with α-Synucleinopathies
deleteMovement Disorders
IF7.6
delete2026-08-10
delete0
PREAI
deleteChenxin Ying MD; Xinhui Chen MD; Zhidong Cen MD, PhD; Xinghua Feng PhD; Nan Jin MD; Jiaxiang Li MD; Xinchen Wang MD; Wei Luo MD, PhD
deleteShare
deleteSave
Reply to: “What Does α-Syn-SAA-Negative Parkinson's Disease Reveal about the Proposed “Biological Definition” of Parkinson's Disease?”
deleteMovement Disorders
IF7.6
delete2026-08-05
delete0
PREAI
deleteSarah M. Brooker MD, PhD; Kenneth Marek MD; Kathleen L. Poston MD
deleteShare
deleteSave
Expanding the Motor Phenotype and Molecular Spectrum of NAA15-Related Disorder: Two Cases of Isolated Childhood-Onset Gait Dystonia
deleteMovement Disorders
IF7.6
delete2026-08-05
delete0
PREAI
deleteKathryn Yang MD, FRCPC; Martino Montomoli MD; Josh Rong BSc; Amy Tam BSc; Monica Ferrer Socorro MD; Claire Miller MD, PhD; Darius Ebrahimi-Fakhari MD, PhD
deleteShare
deleteSave
Real-World Evaluation of Bilateral Magnetic Resonance–Guided Focused Ultrasound Thalamotomy in Essential Tremor
deleteMovement Disorders
IF7.6
delete2026-08-05
delete0
deleteOAAI
deleteDolores Vilas MD, PhD; Antonio Gonzalez MD; Manel Tardáguila MD; Lourdes Ispierto MD, PhD; Mireia Gea MD; José Antonio Pérez RN; Raquel García RN; Ramiro Álvarez MD, PhD; Jorge Muñoz MD, PhD
deleteShare
deleteSave
Complementary Mitochondrial and α-Synuclein Signatures Refine Biological Stratification of Parkinson's Disease
deleteMovement Disorders
IF7.6
delete2026-08-05
delete0
deleteOAAI
deleteJulia C. Fitzgerald PhD; Patrick May PhD; Anne Grünewald PhD
deleteShare
deleteSave
What Does α-Syn-SAA-Negative Parkinson's Disease Reveal About the Proposed “Biological Definition” of Parkinson's Disease?
deleteMovement Disorders
IF7.6
delete2026-08-05
delete0
PREAI
deleteAlberto J. Espay MD, MSc; Francisco Cardoso MD, PhD; Steven J. Frucht MD; Alberto Imarisio MD; Andrew J. Lees FMed Sci, FRCP
deleteShare
deleteSave
Reply to: Complementary Mitochondrial and α-Synuclein Signatures Refine Biological Stratification of Parkinson's Disease
deleteMovement Disorders
IF7.6
delete2026-08-05
delete0
PREAI
deleteMarco Percetti MD; Vidal Yahya MD; Alessio Di Fonzo MD, PhD; Edoardo Monfrini MD, PhD
deleteShare
deleteSave
A Gap Analysis of Deep Brain Stimulation for Childhood-Onset Movement Disorders
deleteMovement Disorders
IF7.6
delete2026-08-04
delete0
deleteOAAI
deleteDaniela Munoz-Chesta MD, MSc; Carolina Gorodetsky MD, MSc; Todd M. Herrington MD, PhD; Angela L. Hewitt MD, PhD; Daniel E. Lumsden MD, PhD, FRCPCH1; Jennifer O'Malley MD, PhD; Terence Sanger MD, PhD
deleteShare
deleteSave
Childhood-Onset Movement Disorders at the Forefront: From Genes to Precision Therapy
deleteMovement Disorders
IF7.6
delete2026-08-04
delete0
PREAI
deleteKathryn Yang MBChB, FRCPC; Darius Ebrahimi-Fakhari MD, PhD
deleteShare
deleteSave
Epilepsy-Dyskinesia Syndromes: The Venn Diagram of Genetic Epilepsy and Movement Disorders
deleteMovement Disorders
IF7.6
delete2026-08-04
delete0
PREAI
deleteKaterina Bernardi MD; Julian E. Alecu MD; Christelle Moufawad El Achkar MD; Laura Tochen MD; Phillip L. Pearl MD; Darius Ebrahimi-Fakhari MD, PhD
deleteShare
deleteSave